The incidence and risk factors analysis of acute kidney injury in hospitalized patients received diuretics: A single-center retrospective study
- PMID: 35935825
- PMCID: PMC9355122
- DOI: 10.3389/fphar.2022.924173
The incidence and risk factors analysis of acute kidney injury in hospitalized patients received diuretics: A single-center retrospective study
Abstract
Diuretics have been one of the well-known nephrotoxic drugs which can lead to acute kidney injury (AKI). However, there are few real-world studies on the incidence of AKI in hospitalized patients received diuretics. In the present study, a single-center retrospective study was conducted in our center. The clinical data of hospitalized patients received diuretics from January 2018 to December 2020 was retrospectively analyzed. Among the 18,148 hospitalized patients included in the study, 2,589 patients (14.26%) were judged as incidence with AKI, while only 252 patients were diagnosed with AKI in the medical record. Among diuretics drugs in the study, the incidence rate of AKI with torasemide was the highest with 21.62%, and hydrochlorothiazide had the lowest incidence rate (6.80%). The multiple logistic regression analysis suggested that complicated with hypertension, anemia, pneumonia, shock, sepsis, heart failure, neoplastic diseases, combined use of proton pump inhibitors (PPI) were independent risk factors for AKI related to diuretics. The logic regression models for diuretics related AKI were developed based on the included data. The model for diuretics-AKI achieved the area under the receiver operating characteristic curves (AUC) with 0.79 on 10-fold cross validation. It is urgent to improve the understanding and attention of AKI in patients received diuretics for medical workers, and the assessment of risk factors before the use of diuretics should be contributed to the early prevention, diagnosis and treatment of AKI, and ultimately reducing morbidity and improving prognosis.
Keywords: acute kidney injury; diuretics; logic regression model; miss diagnosis; pharmacoepidemiology; risk factors.
Copyright © 2022 Zhang, Liu, Cao, Lao, Wang, Li, Huang, Tang and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Risk-factor analysis and predictive-model development of acute kidney injury in inpatients administered cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium: a single-center retrospective study.Front Pharmacol. 2023 Jun 8;14:1170987. doi: 10.3389/fphar.2023.1170987. eCollection 2023. Front Pharmacol. 2023. PMID: 37361226 Free PMC article.
-
The incidence of acute kidney injury in hospitalized patients receiving aminoglycoside antibiotics: a retrospective study.Eur Rev Med Pharmacol Sci. 2022 May;26(10):3718-3725. doi: 10.26355/eurrev_202205_28868. Eur Rev Med Pharmacol Sci. 2022. PMID: 35647854
-
[Risk factors of acute kidney injury in hospitalized patients with infective endocarditis and their predictive values].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Sep;32(9):1074-1079. doi: 10.3760/cma.j.cn121430-20200630-00497. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33081893 Chinese.
-
Incidence and Cost of Acute Kidney Injury in Hospitalized Patients with Infective Endocarditis.J Clin Med. 2019 Jun 27;8(7):927. doi: 10.3390/jcm8070927. J Clin Med. 2019. PMID: 31252690 Free PMC article. Review.
-
Diuretics in acute kidney injury.Semin Nephrol. 2011 Nov;31(6):523-34. doi: 10.1016/j.semnephrol.2011.09.007. Semin Nephrol. 2011. PMID: 22099509 Review.
Cited by
-
Risk-factor analysis and predictive-model development of acute kidney injury in inpatients administered cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium: a single-center retrospective study.Front Pharmacol. 2023 Jun 8;14:1170987. doi: 10.3389/fphar.2023.1170987. eCollection 2023. Front Pharmacol. 2023. PMID: 37361226 Free PMC article.
-
Real-world data and Mendelian randomization analysis in assessing adverse reactions of rilonacept.Int J Clin Pharm. 2025 Jul 2. doi: 10.1007/s11096-025-01932-0. Online ahead of print. Int J Clin Pharm. 2025. PMID: 40601088
-
Machine learning modeling for the risk of acute kidney injury in inpatients receiving amikacin and etimicin.Front Pharmacol. 2025 May 22;16:1538074. doi: 10.3389/fphar.2025.1538074. eCollection 2025. Front Pharmacol. 2025. PMID: 40487395 Free PMC article.
-
Developing a machine learning model for predicting venlafaxine active moiety concentration: a retrospective study using real-world evidence.Int J Clin Pharm. 2024 Aug;46(4):899-909. doi: 10.1007/s11096-024-01724-y. Epub 2024 May 16. Int J Clin Pharm. 2024. PMID: 38753076
-
Artificial Intelligence-Driven Drug Toxicity Prediction: Advances, Challenges, and Future Directions.Toxics. 2025 Jun 23;13(7):525. doi: 10.3390/toxics13070525. Toxics. 2025. PMID: 40710970 Free PMC article. Review.
References
-
- Awdishu L., Mehta R. L. (2017). The 6R's of drug induced nephrotoxicity. BMC Nephrol. 18 (1), 124. 10.1186/s12882-017-0536-3 PubMed Abstract | 10.1186/s12882-017-0536-3 | Google Scholar - DOI - DOI - PMC - PubMed
-
- Davis S. E., Lasko T. A., Chen G., Siew E. D., Matheny M. E. (2017). Calibration drift in regression and machine learning models for acute kidney injury. J. Am. Med. Inf. Assoc. 24 (6), 1052–1061. 10.1093/jamia/ocx030 PubMed Abstract | 10.1093/jamia/ocx030 | Google Scholar - DOI - DOI - PMC - PubMed
-
- de Figueiredo T. P., de Souza Groia R. C., Barroso S. C. C., do Nascimento M. M. G., Reis A. M. M. (2017). Factors associated with adverse drug reactions in older inpatients in teaching hospital. Int. J. Clin. Pharm. 39 (4), 679–685. 10.1007/s11096-017-0473-z PubMed Abstract | 10.1007/s11096-017-0473-z | Google Scholar - DOI - DOI - PubMed
-
- Fenna K., Erasmus R. T., Zemlin A. E. (2019). Hospital-acquired acute kidney injury prevalence in in adults at a South African tertiary hospital. Afr. Health Sci. 19 (2), 2189–2197. 10.4314/ahs.v19i2.44 PubMed Abstract | 10.4314/ahs.v19i2.44 | Google Scholar - DOI - DOI - PMC - PubMed
-
- Formica M., Politano P., Marazzi F., Tamagnone M., Serra I., Marengo M., et al. (2018). Acute kidney injury and chronic kidney disease in the elderly and polypharmacy. Blood Purif. 46 (4), 332–336. 10.1159/000492149 PubMed Abstract | 10.1159/000492149 | Google Scholar - DOI - DOI - PubMed
LinkOut - more resources
Full Text Sources